Table 1.
Demographics and clinical characteristics of patient cohort.
| IFN n = 7 | IFN+ARB n = 46 | ARB n = 24 | P-value | |
|---|---|---|---|---|
| Age, years | 41.3 (27–68) | 40.4 (25–80) | 64.5 (37–73) | <0.001 |
| Male (%) | 0 (0.0%) | 20 (43.5%) | 11 (45.8%) | 0.076 |
| Female (%) | 7 (100%) | 26 (56.5%) | 13 (54.2%) | |
| Co-morbidities (%)a | 14.3% | 15.2% | 54.2% | 0.002 |
| Initial symptoms | ||||
| Fever (%) | 57.1% | 58.7% | 70.8% | 0.632 |
| Cough (%) | 42.9% | 50.0% | 54.2% | 0.888 |
| Fatigue (%) | 14.3% | 23.9% | 37.5% | 0.422 |
| Myalgia (%) | 14.3% | 13.0% | 29.2% | 0.228 |
| Headache (%) | 14.3% | 6.52% | 4.17% | 0.590 |
| Pharyngalgia (%) | 0.00% | 13.0% | 8.33% | 0.742 |
| Chest pain (%) | 14.3% | 6.52% | 20.8% | 0.134 |
| Expectoration (%) | 14.3% | 8.70% | 20.8% | 0.281 |
| Nausea (%) | 0.00% | 0.00% | 4.17% | 0.403 |
| Diarrhea (%) | 14.3% | 4.35% | 20.8% | 0.081 |
| Days from symptom onset to hospital admissionb | 8.0 [5.5, 15.5] |
6.5 [3.0, 10.0] |
10.0 [4.5, 19.5] |
0.087 |
| Days from symptom onset to 1st treatmentb | 8.0 [6.5, 16.0] |
8.0 [5.25, 11.0] |
17.0 [10.0, 22.0] |
<0.001 |
a
Hypertension, diabetes, COPD, chronic bronchitis, heart disease, cancer.
b
Median and interquartile range [Q1, Q3] is reported.